Advice beyond your investment portfolio
Whether you’re seeking to accumulate, preserve or transfer assets to the next generation, you can benefit from the guidance of a well-qualified Financial Advisor.
At The Biederman Group, we aim to provide personalized strategies to help you negotiate life’s transitions and navigate today’s complex financial markets. Our coordinated wealth management strategies go far beyond investing to encompass every aspect of your financial life:
Our discretionary investment management approach features carefully selected third party managers with records of superior performance in bull, bear and neutral markets. As a Certified Investment Management® Analyst (CIMA), Dan Biederman, Senior Vice President, Senior Investment Management Consultant and the team’s founder, is well qualified to help you develop a strategy that meets your specific objectives, timeframe and risk tolerance.
Investment strategies change as you approach retirement. Asset accumulation may still be important, but perhaps not so much as income generation. We help you quantify anticipated expenses, plan for unanticipated ones and invest your assets seeking to generate income that sees you through your retirement years.
We work closely with your attorney and accountant to help create and implement an estate plan strategy that seeks to eliminate excessive taxation, while minimizing family turmoil. For many of our clients, we confer with children and other beneficiaries to set expectations and educate them on the responsibilities their inheritance will someday require.
The Biederman Group at Morgan Stanley can help make a difference in your financial life, while seeking to secure the futures of your children and grandchildren. We take pride in the depth and longevity of our client relationships and the fact that so many of them extend from generation to generation.
See September On the Markets from the Global Investment Committee featuring
• “Attitude Matters” Michael Wilson, chief investment officer of Morgan Stanley Wealth Management, says few investors believe the world can overcome the obstacles it faces. And this attitude, he adds, prevents them from seeing and acting on positive developments.
• “Say What? Biotech Is Cheaper Than Pharma?” Historically, US biotechnology stocks have traded at a big premium to big European and US pharmaceutical companies because of their much faster growth rate. But now, for a variety of reasons, biotech is on a par with big pharma or even cheaper. Adam Parker, chief US equity strategist for Morgan Stanley & Co., explains how this anomalous behavior came to be.
• "Higher Oil Prices and Reforms Give MLPs a Lift" Last year, midstream master limited partnerships faced a perfect storm of lower commodity prices, falling US hydrocarbon production and rising interest rates—and the results were brutal. Now, attractive valuation, higher energy prices and industry reforms give MLPs a brighter outlook, writes Vijay Chandar, market strategist for Morgan Stanley Wealth Management.
• Plus, look for more on equities, fixed income and a Q&A with Morgan Stanley Investment Management’s Ruchir Sharma about the changing nature of the emerging markets.
As the managed money unit of Morgan Stanley, Consulting Group has a long history of providing investment consulting advice and services to a broad range of individual and institutional clients. Their mission is to provide the highest level of sophisticated financial advice; objective investment manager, economic and capital markets research; and asset allocation advice to our clients.
Meet with me and our specialists to discuss valuable ideas and individually tailored wealth planning strategies to help you preserve your wealth
Check the background of our Firm and Investment Professionals on FINRA's BrokerCheck.